{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:41Z","timestamp":1792172561185,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijrobp.2023.01.047","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T20:35:35Z","timestamp":1675197335000},"page":"797-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated With Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase 2, Randomized Clinical Trial"],"prefix":"10.1016","volume":"116","author":[{"given":"Sung Jun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Iovoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Neimanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.01.047_bib0001","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cncr.21622","article-title":"Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma","volume":"106","author":"Vera-Llonch","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0003","article-title":"Status of treatment and prophylaxis for radiation-induced oral mucositis in patients with head and neck cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0004","article-title":"Oral mucositis due to high-dose chemotherapy and\/or head and neck radiation therapy","volume":"2019","author":"Lalla","year":"2019","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/0194599813517081","article-title":"Prophylactic versus reactive PEG tube placement in head and neck cancer","volume":"150","author":"Kramer","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0006","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cncr.23714","volume":"113","author":"Nonzee","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002820-200212000-00010","article-title":"Complications of radiation therapy for head and neck cancers. The patient's perspective","volume":"25","author":"Rose-Ped","year":"2002","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0008","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamaoto.2013.5193","article-title":"Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer","volume":"139","author":"Strom","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(99)00558-1","article-title":"Toxicity in head and neck cancer: A review of trends and issues","volume":"47","author":"Trotti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0011","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0012","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cncr.32676","article-title":"A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer","volume":"126","author":"Hermann","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0013","unstructured":"National Comprehensive Cancer Network. Head and neck cancers (version 1.2022). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed December 16, 2021."},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0014","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/eujp.2001.0266","article-title":"Venlafaxine in neuropathic pain following treatment of breast cancer","volume":"6","author":"Tasmuth","year":"2002","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0017","first-page":"1999","article-title":"Treatment of neuropathic pain with venlafaxine: A systematic review","volume":"18","author":"Aiyer","year":"2017","journal-title":"Pain Med"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0018","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-018-3664-y","article-title":"Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy","volume":"82","author":"Farshchian","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0019","first-page":"1071","article-title":"MC11C4: A pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy","volume":"24","author":"Zimmerman","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12900","article-title":"Association of gabapentin use with pain control and feeding tube placement among patients with head and neck cancer receiving chemoradiotherapy","volume":"5","author":"Ma","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5306\/wjco.v3.i4.57","article-title":"A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer","volume":"3","author":"Fung-Kee-Fung","year":"2012","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0023","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hed.23024","article-title":"Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck","volume":"35","author":"Platek","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0024","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clinthera.2011.12.004","article-title":"Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study","volume":"34","author":"Lal","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0026","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cncr.22620","article-title":"Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire","volume":"109","author":"Epstein","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0027","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0028","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","article-title":"Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement","volume":"50","author":"Groenvold","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archotol.126.4.459","article-title":"Assessing quality of life in patients with head and neck cancer: Cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35)","volume":"126","author":"Sherman","year":"2000","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0031","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hed.20938","article-title":"Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery","volume":"31","author":"Singer","year":"2009","journal-title":"Head Neck."},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0032","first-page":"678","article-title":"Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: Randomized, double-blind, placebo-controlled clinical trial","volume":"139","author":"Lydiatt","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0033","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/archotol.134.5.528","article-title":"A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer","volume":"134","author":"Lydiatt","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/jpn.0909","article-title":"Optimal use of antidepressants: When to act?","volume":"34","author":"Blier","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/AJP.0b013e3181cb406e","article-title":"Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain","volume":"26","author":"Amr","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0036","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00455-014-9521-1","article-title":"Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer","volume":"29","author":"Starmer","year":"2014","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0037","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hed.21165","article-title":"Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy","volume":"32","author":"Bar Ad","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0038","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2019.11.051","article-title":"Prophylactic gabapentin results in dramatic reduction of narcotic utilization in head and neck cancer patients undergoing radiotherapy","volume":"106","author":"Mandia","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0039","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/hed.26407","article-title":"Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation","volume":"42","author":"Smith","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0040","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ijrobp.2021.11.012","article-title":"Randomized phase 3, double-blind, placebo-controlled study of prophylactic gabapentin for the reduction of oral mucositis pain during the treatment of oropharyngeal squamous cell carcinoma","volume":"112","author":"Cook","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0041","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00455-015-9679-1","article-title":"Predictive factors for prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement and use in head and neck patients following intensity-modulated radiation therapy (IMRT) treatment: Concordance, discrepancies, and the role of gabapentin","volume":"31","author":"Yang","year":"2016","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2023.01.047_bib0042","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/JEP.S124391","article-title":"Review about gabapentin misuse, interactions, contraindications and side effects","volume":"9","author":"Quintero","year":"2017","journal-title":"J Exp Pharmacol"},{"issue":"suppl 2","key":"10.1016\/j.ijrobp.2023.01.047_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004850-199503002-00004","article-title":"Safety and tolerance profile of venlafaxine","volume":"10","author":"Danjou","year":"1995","journal-title":"Int Clin Psychopharmacol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:07:35Z","timestamp":1759745255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0360301623000846"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.047","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated With Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase 2, Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}